West Pharmaceutical Services, Inc.
WST
$214.55
$3.961.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.85% | -16.97% | -10.69% | 1.20% | 3.01% |
| Total Depreciation and Amortization | 13.09% | 13.18% | 13.66% | 15.40% | 15.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.00% | -96.37% | 481.01% | -0.20% | 14.64% |
| Change in Net Operating Assets | 558.54% | 114.22% | -90.79% | 173.68% | 29.31% |
| Cash from Operations | -12.16% | -15.85% | -8.57% | 6.42% | 6.43% |
| Capital Expenditure | 3.45% | -4.14% | -9.36% | -27.43% | -23.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.63% | 74.63% | 70.77% | 87.34% | -509.09% |
| Cash from Investing | 4.72% | -2.71% | -7.89% | -24.58% | -24.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7,576.00% | -7,916.67% | -8,291.30% | -36.34% | 94.36% |
| Issuance of Common Stock | -61.33% | -35.88% | -38.30% | 14.88% | 48.73% |
| Repurchase of Common Stock | 34.02% | -25.58% | -151.40% | -143.07% | -409.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.47% | -3.68% | -4.09% | -4.12% | -5.11% |
| Other Financing Activities | -- | -- | 0.00% | 0.00% | -- |
| Cash from Financing | 24.41% | -35.47% | -165.81% | -110.86% | -243.72% |
| Foreign Exchange rate Adjustments | 2.33% | -287.72% | -55.74% | -123.83% | -368.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.54% | -814.11% | -340.39% | -550.00% | -230.15% |